Jim is responsible for diagnostics-related programs and activities for the Global Health Institute.
Jim has a proven track record in Global Health with the development and commercialization of the current MUSE Auto CD4/CD4% system, a laboratory instrument designed to monitor T cells in adult and pediatric patients suffering from HIV/AIDS, malaria, and COVID 19 in developing countries.
Jim has more than 30 years of experience in the pharmaceutical/ diagnostic/ biotechnology industry, including 10 years in Life Science. He has efficiently led sales and marketing organizations at Abbott Diagnostics and Horiba Medical. Before joining Merck KGaA, Darmstadt, Germany, Jim has conducted management in three start-up organizations and has taken these companies from incubation to profit. He has an extensive network with the United Nations and other non-government organizations in the field of Global Health.
Jim holds a BS in Psychology from the University of Houston and attended the Graduate School of Management at the University of Dallas.